XML 30 R19.htm IDEA: XBRL DOCUMENT v3.26.1
Stock-based Compensation
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Stock-based Compensation

Note 10. Stock-based Compensation

 

During the years ended December 31, 2025 and 2024, there was no stock-based compensation associated with stock options included in research and development expense. The Company issued 100,000 shares of common stock for services during each of the years ended December 31, 2025 and 2024. A portion of these shares related to services that had not yet been performed at the time of issuance and were recorded as prepaid expenses. Such prepaid amounts were subsequently recognized as expense as the related services were performed. Accordingly, the Company recognized $7,550 and $1,258, respectively, of expense associated with shares issued for services in research and development, and $19,250 and $0, respectively, in general and administrative expense.  

 

There were no options granted during the years ended December 31, 2025 and 2024. There were no options exercised, forfeited or cancelled during either period but all options did expire during the year ended December 31, 2025.

 

As of December 31, 2024, all compensation related to the 1,100,000 outstanding options has been recognized. The options were expensed over the vesting period for each Advisor.

 

All outstanding options expired during the year ended December 31, 2025. Options outstanding at December 31, 2024 consist of:

 

Date Issued  Number
Outstanding
   Number
Exercisable
   Exercise Price   Expiration Date
June 27, 2020   150,000    150,000   $0.40   June 27, 2025
January 1, 2021   450,000    450,000   $0.65   December 31, 2025
Total   600,000    600,000         

 

Warrants outstanding at December 31, 2025 consist of:

 

Date Issued  Number
Outstanding
   Number
Exercisable
   Exercise Price   Expiration Date
December 31, 2025   416,666    416,666   $0.60   December 31, 2030
Total   416,666    416,666         

 

Warrants outstanding at December 31, 2024 consist of:

 

Date Issued  Number
Outstanding
   Number
Exercisable
   Exercise Price   Expiration Date
July 19, 2022   550,000    550,000   $0.50   July 18, 2025
Total   550,000    550,000